Skip to main content
. 2018 Dec 14;19:198. doi: 10.1186/s12875-018-0876-5

Table 5.

Comparison of Co-morbid Conditions found in Nocturnal Enuretics in Comparison with Non- Nocturnal Enuretics (n = 429)

Variables Nocturnal Enuretics (n = 183) Nonuretics (n = 246) P-value
Presence of constipation (either hard to pass stools or < twice per week)Yes 42 (23.0) 29 (11.9) 0.002*
Developmental delay 14 (7.7) 4 (1.6) 0.004*
Congenital Defect 7 (3.8) 04 (1.6) 0.102*
Physical delay 16 (8.7) 10 (4.1) 0.010
Allergy 20 (10.9) 26 (10.1) 0.869
Learning problem 14 (7.7) 14 (5.8) 0.002*
Asthma 11 (6.0) 11 (4.5) 0.045
Diabetes Mellitus
Sleep problem 42 (22.9) 22 (9) 0.001*
Seizures 01 (0.5) 01 (0.4) 0.930
Kidney or bladder problems 4 (2.2)
Urinary tract infection 14 (7.7) 1 (0.4) < 0.001*
Use of medication 20 (10.9) 10 (4.1) 0.006
Medical problem, condition or disease 20 (10.9) 10 (4.1) < 0.001*

*P-value significant at 0.05 level